Roles of Kampo medicine in treating rheumatic diseases

Journal of Traditional Medicines

Volumn 24, Issue 3, 2007, Pages 73-80

  Ohno, Shuji ^a  

^a Ohno Clinic   (Japan)

Author keywords

Bakumondoto; Kampo medicine; rheumatic diseases; Saireito; Sj gren's syndrome; SLE

Indexed keywords

EID: 85009539483     PISSN: 18801447     EISSN: 18813747     Source Type: Journal    
DOI: 10.11339/jtm.24.73     Document Type: Article

References (46)

1. Auphan, N., DiDonato, J. A., Rosette, C., Helmberg, A., Karin, M.: Immunosuppression by glucocorticoids; inhibition of NF-kappa B activity through induction of I kappa B synthesis. Science. 270, 286-290, 1995.
2. Ichikawa, Y.: Collagen diseases - how to use steroids in immunological diseases. Japanese Medical Journal 3805, 21-27, 1997.
3. Gold, R., Buttgereit, F., Toyka, KV.: Mechanism of glucocorticosteroid hormones : possible implications for therapy of neuroimmunological disorders. J. Neuroimmnol. 117, 1-8, 2001.
4. Bernes, PJ.: Molecular mechanisms and cellular effects of glucocorticosteroids. Immunol. Allergy Clin. North Am. 25, 451-468, 2005.
5. Ohno, S., Suzuki, T.: Combination therapy with Boiogito and Lobenzarit for rheumatoid arthritis. Clinical Rheumatology and Related Research 3, 135-142, 1990.
6. Matsuta, K., Tsuchiya, N., Takeuchi, N., Mori, M., Nakano, K.: Clinical effect and safety of combination of Lobenzarit disodium with Boiogito in rheumatoid arthritis. Rheumatology 14 (2), 169-176, 1995.
7. Mark, J. Borigini, Marlene J. Egger, H. James, Williams, Harold, E. Paulus, John, R. Ward.: TJ-114 (Sairei-to), an Herbal Medicine in Rheumatoid Arthritis: A Preliminary “Go - No Go” Clinical trial. Journal of Clinical Rheumatology 2 (6), 309-316, 1996.
8. Ohno, S.: Combination therapy with DMARDs and Kampo medicine (extracts). Rheumatology 27 (4), 418-424, 2002.
9. Takahashi, K., Matsuda, H., Shimada, Y., Kita, T., Itoh, T., Terasawa, K.: Correlation between the activity of rheumatoid arthritis and the severity of the “oketsu” syndrome. Journal of Traditional Medicine 15, 123-126, 1998.
10. Nagasaka, K., Hikitsuna, H., Tatsumi, T., Tosa, H., Terasawa, K.: Investigation of 43 patients with rheuematoid arthritis. Journal of the Japan Society for Oriental Medicine 51 (2), 241-245, 2000.
11. Yoshida, T., Akitsuki, M.: Kampo therapy and Quality of Life in rheumatoid arthritis. Gendai Toyo Igaku 16 (2), 135-141, 1995.
12. Mori, K., Ohno, S., Imai, T., Tanaka, M., Suzuki, T., Doi, Y. : Patients with rheumatoid arthritis treated with Kampo therapy. Journal of the Japan Society for Oriental Medicine 44 (2), 217-221, 1993.
13. Imadaya, A. : A case of systemic erythematosus in long remission after steroid was discontinued with Kampo therapy. Gendai Toyo Igaku 10, 104 -105, 1989.
14. Hikitsuna, H., Kogure, T., Kita, T., Shimada, Y., Terasawa, K.: A case of intractable thrombopenia of systemic erythematosus that was successfully treated with Juzendaihoto. Journal of the Japan Society for Oriental Medicine 48, 327-333, 1997.
15. Ito, T.: A case of systemic erythematosus for which Saireito proved effective. Journal of the Japan Society for Oriental Medicine 42 (3), 349-352, 1992.
16. Shibazaki, T., Matsuda, H., Ohno, I., Ishii, F., Sakai, N.: Three cases of lupus nephritis that responded to Saireito over a long period. Journal of the Medical and Pharmaceutical Society for Wakan-yaku 13, 410-411, 1996.
17. Ohno, S.: Case 1; pre-SLE symptoms cured only with Kampo medicine. Case 2; improvement of Raynaud's phenomenon, facial erythema, polyarthritis, lymphadenitis and leucopenia of mild SLE only with Kampo medicine. Case 3; a patient with SLE whose renal function deteriorated after administration of Orengedoku but who could subsequently discontinue steroids after Saireito administration. Case 4; a SLE patient with Jaccoud's arthritis and repeated onset of fever due to the appearance of various autoantibodies. Case 5; a SLE patient whose fever and facial erythema were improved with Byakkokaninjinto. in “Manual for Kampo Treatment of Collagen Diseases and Immunological Diseases” pp. 60–68, Gendai Shuppan Planning, Tokyo, 2004.
18. Mizushima, T. : Three cases of SLE who became negative for anti-nuclear antibodies concurrently with an improvement of skin symptoms. Gendai Toyo Igaku 13, 212-215, 1992.
19. Arai, S., Sato, H., Daita, F.: A patient with SLE whose anti-nuclear antibody became negative when the skin symptoms were improved with Shosaikoto + Orengedokuto + Yokuinin. Kampo Medicine 51 (2), 247-254, 2000.
20. Takemura, S., Kondo, M.: Effects of Shosaikoto on systematic erythematosus. Gendai Toyo Igaku 11, 82-83, 1990.
21. Imai, T., Ohno, S., Asaoka, T., Tanaka, M., Akiyama, Y., Suzuki, T., Doi, Y.: A case of rheumatic multiple myalgia that responded to Kampo medicine. Journal of the Japan Society for Oriental Medicine 45 (3), 535-599, 1995.
22. Katagiri, T., Ohno, S., Akiyama, Y., Asaoka T., Imai, T., Tanaka, M., Suzuki, T., Doi, Y.: A case of intractable polymyositis improved with Kampo medicines (Rokumigan, Choreito). Journal of the Japan Society for Oriental Medicine 45 (4), 881-885, 1995.
23. Tsustsui, K.: Experience of using Saireito in intractable dermatomyositis. Kampo Shinryo 15 (4), 15-18, 1996.
24. Ohno, S.: A case of PN in which Kampo medicine led to discontinuation of steroids. in “Manual for Kampo Treatment of Collagen Diseases and Immunological Diseases” pp. 149–151, Gendai Shuppan Planning, Tokyo, 2004.
25. Ohno, S.: Case 1; MCTD fully recovered only with Kampo medicine. Case 2; a patient with MCTD whose interstitial pneumonia was resolved with Kampo medicine. in “Manual for Kampo Treatment of Collagen Diseases and Immunological Diseases” pp. 136–140, Gendai Shuppan Planning, Tokyo, 2004.
26. Ohno, S., Suzuki, T., Doi, Y. : A case of marked improvement of dry mouth, polyarthralgia, and Raynaud's phenomenon associated with Sjögren's syndrome with Bakumondoto, a Kampo formulation. Clinical Allergology (Allergy no Rinsho) 8 (10), 40-43, 1988.
27. Yamada, M. : Experience in Kampo treatment of patients suspected of Sjögren's syndrome and subacute myelooptic neuropathy. Journal of the Japan Society for Oriental Medicine 17 (4), 15-17, 1967.
28. Ebe, Y. : A case of RA Sjögren's syndrome. Gendai Toyo Igaku 5 (1), Extra Number. 60-61, 1984.
29. Kogure, T., Watanabe, M., Ito, T., Shimada, Y., Teasawa, K.: Application of Unkeito in primary Sjögren's syndrome. Journal of the Japan Society for Oriental Medicine 80 (3), 349-355, 1997.
30. Ohno, S. : Cases of marked improvement of symptoms, increased salivation, improvement of hypergammaglobulinemia and improvement of systemic symptoms. in “Manual for Kampo Treatment of Collagen Diseases and Immunological Diseases” pp. 116–117, Gendai Shuppan Planning, Tokyo, 2004.
31. Yamauchi, K.: Sjögren's syndrome and Kampo therapy. Gendai Toyo Igaku 16 (1), 41-51, 1995.
32. Maki, K., Kagami, H., Ohno, K. and Ueda, M.: Clinical Study of Patients with Dry Mouth - Indication and Efficacy of the Oriental Herbal Medicine “Bakumondoto”. Ronen Shika Igaku (Geriatric Dental Medicine) 11 (2), 111-117, 1996.
33. Ohno, S., Suzuki, T., Doi, Y.: Effect of Bakumondoto on salivation in Sjögren's syndrome. Rheumatology 30 (1), 10-16, 1990.
34. Ohno, S.: RCT for Kampo medicine in immunological diseases - effect of Kampo therapy on salivation disorder in Sjögren's syndrome. Kampo and the Newest Therapy 15 (2), 134-140, 2006.
35. Ohno, S.: Case showing a tendency for improvement of scleroderma and remission of interstitial pneumonia after typical combination therapy of PSL and Kampo medicine. in “Manual for Kampo Treatment of Collagen Diseases and Immunological Diseases” pp. 92–95, Gendai Shuppan Planning, Tokyo, 2004.
36. Akiyama, Y., Ohno, S., Asaoka, T., Katagiri, T., Takeishi, M., Omata, H., Suzuki, T.: Combination Therapy with Sarpogrelate and Kampo Medicine (Orengedokuto or Tokishakuyakusan) for Raynaud's phenomenon. Journal of the Japan Society for Oriental Medicine 5 (5), 1101-1108, 2001.
37. Yano, R., Kashu, Y., Kitano, M.: Effect of Ninjinyoeito in the cold water endurance test of pachydermia patients. Kampo and the Newest Therapy 10 (3), 250-252, 2001.
38. Ohtsuka, T., Yamakage, A., Yamasaki, T.: Kampo medicine and 3H-TdR uptake in fibroblast cultures derived from the hardened skin of a diffuse pachydermia patient; effect of Kampo medicine on fibroblasts in pachydermia. Kampo Igaku 21 (10), 16-18, 1997.
39. Nishiyama, K., Ishi, S.: Effect of Saireito on proteinuria in chronic nephritis. Pharma Medica (extra issue) 6, 8-13, 1988.
40. Abe, H.: Combination therapy with steroid and Kampo medicine - focusing on Saireito. Gendai Iryogaku (Modern Medicine) 8, 207-212, 1993.
41. Shibata, M., Suzuki, Y., Yamamoto, J., Mizutani, T., Maeda, K., Ryoukado, K., Kato, K., Futenma, S., Niimura, I., Sugiyama, T., Okazaki, Y., Nakamura, T., Yamazaki, C., Tamaki, S., Tsuruta, Y., Iwata, J., Ohkura, Y., Ohashi, H., Shimomura, A. : Kampo ethical drugs in chronic glomerular nephritis (including nephrotic syndrome); clinical effects of Saikokaryukotsuboreito (TJ-107), Gyushajinkigan (TJ-107) and Saireito (TJ-114). Jin To Toseki (Kidney and Dialysis) 31, 779-787, 1991.
42. Tojo, S., Yoshitoshi, K., Nagasawa, T., Narita, M., Miyahara, T., Nishiyama, K., Hatano, M., Honda, N.: Ethical Kampo drug in chronic glomerular nephritis and nephrotic syndrome; clinical effect of Saireito (TJ-114) (First report). Jin To Toseki 31, 613-625, 1991.
43. Kogure, T., Niizawa, A., Fujinaga, H., Sakai, S., Hai, LX., Shimada, Y., Terasawa, K.: A case of rheumatoid arthritis with a decrease in the serum concentrations of soluble CD23 after administration of a traditional herbal medicine. J. Trad. Med 16 (5/6), 190-195, 1999.
44. Kogure, T., Mantani, N., Tahara, E., Shintani, T., Shimada, Y., Tamura, J., Terasawa, K.: Immunological analysis of a KI-disorder based on the traditional Japanese oriental diagnostic system. J. Trad. Med 20 (1), 16-21, 2003.
45. Ohno, S. : Effect of a Kampo drug “Hochuekkito” on NK cell activity. Allergy 37 (2), 107-114, 1988.
46. Takeda, K., Okumura, K.: Analysis of the mechanism of NK cell activation by Hochuekkito. Kampo Igaku 24 (2), 13-15, 2000.